Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Crestor

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

226 API Suppliers, 51 USDMF, 56 CEP/COS, 15 JDMF, 31 EU WC, 107 KDMF, 22 NDC API, 80 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

309 Drugs in Development

309 Drugs in Development

INTERMEDIATES

27 Intermediate Suppliers

27 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1304 FDF Dossiers, 128 FDA Orange Book, 575 Europe, 88 Canada, 118 Australia, 104 South Africa, 291 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 10MG BASE, CAPSULE;ORAL - EQ 20MG BASE, CAPSULE;ORAL - EQ 40MG BASE, CAPSULE;ORAL - EQ 5MG BASE, TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 40MG BASE, TABLET;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 19 SPI Pharma, 5 DKSH, 7 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 2 Kirsch Pharma, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 Avesta Pharma, 21 BASF, 1 CD Formulation, 1 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 1 Finar, 10 Gangwal Chemicals, 5 Ideal Cures, 3 Ingredion Pharma Solutions, 26 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 17 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 40 Direct Compression, 28 Granulation, 26 Disintegrants & Superdisintegrants, 25 Lubricants & Glidants, 23 Controlled & Modified Release, 22 Thickeners and Stabilizers, 21 Chewable & Orodispersible Aids, 18 Taste Masking, 14 Co-Processed Excipients, 14 Topical, 12 Solubilizers, 11 Film Formers & Plasticizers, 11 Parenteral, 7 API Stability Enhancers, 6 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 4 Rheology Modifiers, 2 Surfactant & Foaming Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 114 News #PharmaBuzz

GLOBAL SALES INFORMATION

24 US Medicaid Prescriptions, 223 Regulatory FDF Prices, 26 Annual Reports

MARKET PLACE

51 APIs, 15 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents, 12 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 26 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Centrient Pharmaceuticals	Netherlands	CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. Delft NL	CEP 2025-219 - Rev 00	Rosuvastatin calcium, R1-Process	2025-07-30	Valid	Chemical		2631
29/11/2025	TAPI Technology & API Services	Israel	TEVA PHARMACEUTICAL INDUSTRIES LTD Petach Tikva IL	R0-CEP 2015-079 - Rev 00	Rosuvastatin calcium	2016-08-12	Withdrawn by Holder	Chemical	2020-01-16	2631

Crestor

Crestor

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

226 API Suppliers

51 USDMF

56 CEP/COS

15 JDMF

31 EU WC

107 KDMF

22 NDC API

80 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

309 Drugs in Development

INTERMEDIATES

27 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1304 FDF Dossiers

128 FDA Orange Book

575 Europe

88 Canada

118 Australia

104 South Africa

291 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 10MG BASE

CAPSULE;ORAL - EQ 20MG BASE

CAPSULE;ORAL - EQ 40MG BASE

CAPSULE;ORAL - EQ 5MG BASE

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 20MG BASE

TABLET;ORAL - EQ 40MG BASE

TABLET;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem

1 Rochem International Inc

19 SPI Pharma

5 DKSH

7 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

2 Kirsch Pharma

1 ACG Worldwide

3 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

1 Avesta Pharma

21 BASF

1 CD Formulation

1 Clariant

10 Corel Pharma Chem

5 DFE Pharma

1 Esteem Industries

1 Finar

10 Gangwal Chemicals

5 Ideal Cures

3 Ingredion Pharma Solutions

26 Kerry

1 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

3 Pharmatrans-Sanaq

5 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

17 Roquette

7 Seppic